{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:19:54Z","timestamp":1791778794235,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1053\/j.seminhematol.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T14:05:35Z","timestamp":1269957935000},"page":"143-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Treatment of Splenic Marginal Zone Lymphoma: Splenectomy Versus Rituximab"],"prefix":"10.1053","volume":"47","author":[{"given":"Michael","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine P.","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2010.01.004_bib1","first-page":"294","article-title":"Splenic B cell lymphoma with \u201cvillous\u201d lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia","volume":"1","author":"Melo","year":"1987","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00000478-199205000-00004","article-title":"Splenic marginal zone cell lymphoma","volume":"16","author":"Schmid","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib3","first-page":"148","article-title":"Splenic lymphoma with circulating villous lympho-cytes\/splenic marginal-zone lymphoma","volume":"36","author":"Catovsky","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1182\/blood.V83.6.1558.1558","article-title":"The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders","volume":"83","author":"Matutes","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib6","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","article-title":"Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients","volume":"120","author":"Parry-Jones","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","article-title":"Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients","volume":"93","author":"Troussard","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.1991.tb04417.x","article-title":"Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases","volume":"78","author":"Mulligan","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","article-title":"Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients","volume":"3","author":"Thieblemont","year":"2002","journal-title":"Clin Lymphoma"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cncr.21931","article-title":"Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone","volume":"107","author":"Tsimberidou","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib12","first-page":"856","article-title":"Rituximab monotherapy for splenic marginal zone lymphoma","volume":"90","author":"Bennett","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/hon.844","article-title":"Re: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma","volume":"26","author":"Bennett","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hon.820","article-title":"Rituximab monotherapy is highly effective in splenic marginal zone lymphoma","volume":"25","author":"Kalpadakis","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3816\/CLM.2004.n.005","article-title":"Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma","volume":"4","author":"Arcaini","year":"2004","journal-title":"Clin Lymphoma"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib16","article-title":"Significant efficacy of 2-CdA with or without rituximab in the treatment of splenic marginal zone lymphoma (SMZL)","author":"Cervetti","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib17","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chacon","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib18","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cncr.20596","article-title":"Splenic marginal zone lymphoma with or without villous lymphocytes","volume":"101","author":"Iannitto","year":"2004","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2141.1997.3523168.x","article-title":"Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes","volume":"99","author":"Bolam","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib20","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/sj.leu.2403440","article-title":"Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update","volume":"18","author":"Lefrere","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428190009054887","article-title":"Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes","volume":"40","author":"Lefrere","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/hon.717","article-title":"Low dose 2-CdA schedule activity in splenic marginal zone lymphomas","volume":"21","author":"Riccioni","year":"2003","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-0609.2005.00426.x","article-title":"Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes","volume":"75","author":"Iannitto","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib24","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1200\/JCO.2005.12.051","article-title":"Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia","volume":"2","author":"Keating","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib25","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib26","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1080\/10428190701457949","article-title":"Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma","volume":"48","author":"Lossos","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2141.2009.07677.x","article-title":"A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas","volume":"145","author":"Brown","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO;2-W","article-title":"Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes","volume":"91","author":"Franco","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7326\/0003-4819-151-8-200910200-00008","article-title":"Risk for hospital contact with infection in patients with splenectomy","volume":"151","author":"Thomsen","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib30","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","article-title":"Vascular complications after splenectomy for hematologic disorders","volume":"114","author":"Crary","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.01.004_bib31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/thx.2004.038083","article-title":"Splenectomy and chronic thromboembolic pulmonary hypertension","volume":"60","author":"Jais","year":"2005","journal-title":"Thorax"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196310000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196310000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:20:19Z","timestamp":1758522019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196310000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0037196310000053"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2010.01.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Splenic Marginal Zone Lymphoma: Splenectomy Versus Rituximab","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2010.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}